JP4695684B2 - Beverages containing high-concentration theaflavins - Google Patents
Beverages containing high-concentration theaflavins Download PDFInfo
- Publication number
- JP4695684B2 JP4695684B2 JP2008268219A JP2008268219A JP4695684B2 JP 4695684 B2 JP4695684 B2 JP 4695684B2 JP 2008268219 A JP2008268219 A JP 2008268219A JP 2008268219 A JP2008268219 A JP 2008268219A JP 4695684 B2 JP4695684 B2 JP 4695684B2
- Authority
- JP
- Japan
- Prior art keywords
- theaflavins
- weight
- sample
- tea
- beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013361 beverage Nutrition 0.000 title claims description 63
- 235000014620 theaflavin Nutrition 0.000 title claims description 57
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 74
- 244000269722 Thea sinensis Species 0.000 claims description 35
- 125000004122 cyclic group Chemical group 0.000 claims description 29
- 235000010323 ascorbic acid Nutrition 0.000 claims description 28
- 239000011668 ascorbic acid Substances 0.000 claims description 28
- 229960005070 ascorbic acid Drugs 0.000 claims description 28
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 26
- 235000005487 catechin Nutrition 0.000 claims description 26
- 150000001765 catechin Chemical class 0.000 claims description 25
- 229920001353 Dextrin Polymers 0.000 claims description 22
- 239000004375 Dextrin Substances 0.000 claims description 22
- 235000019425 dextrin Nutrition 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 21
- 229920000858 Cyclodextrin Polymers 0.000 claims description 16
- 235000006468 Thea sinensis Nutrition 0.000 claims description 16
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 16
- 229920000642 polymer Polymers 0.000 claims description 14
- 238000001556 precipitation Methods 0.000 claims description 14
- 235000020279 black tea Nutrition 0.000 claims description 13
- 239000012141 concentrate Substances 0.000 claims description 13
- 239000000284 extract Substances 0.000 claims description 12
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 10
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 8
- 229960001948 caffeine Drugs 0.000 claims description 8
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 8
- 238000003860 storage Methods 0.000 claims description 3
- 230000007774 longterm Effects 0.000 claims description 2
- 239000000523 sample Substances 0.000 description 38
- 235000013616 tea Nutrition 0.000 description 27
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 26
- 235000017557 sodium bicarbonate Nutrition 0.000 description 13
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 13
- 235000019658 bitter taste Nutrition 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 11
- 229910052751 metal Inorganic materials 0.000 description 10
- 239000002184 metal Substances 0.000 description 10
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 9
- 229930003268 Vitamin C Natural products 0.000 description 9
- 230000001954 sterilising effect Effects 0.000 description 9
- 235000019154 vitamin C Nutrition 0.000 description 9
- 239000011718 vitamin C Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 238000004659 sterilization and disinfection Methods 0.000 description 8
- 235000019606 astringent taste Nutrition 0.000 description 7
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 7
- 230000035622 drinking Effects 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 6
- 229920001503 Glucan Polymers 0.000 description 5
- IPMYMEWFZKHGAX-UHFFFAOYSA-N Isotheaflavin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1C(O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-UHFFFAOYSA-N 0.000 description 5
- GPLOTACQBREROW-UHFFFAOYSA-N Phlegmanol A-acetat Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(=CC1=2)C=C(O)C(=O)C1=C(O)C(O)=CC=2C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 GPLOTACQBREROW-UHFFFAOYSA-N 0.000 description 5
- KMJPKUVSXFVQGZ-UHFFFAOYSA-N TF2B Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 KMJPKUVSXFVQGZ-UHFFFAOYSA-N 0.000 description 5
- UXRMWRBWCAGDQB-UHFFFAOYSA-N Theaflavin Natural products C1=CC(C2C(CC3=C(O)C=C(O)C=C3O2)O)=C(O)C(=O)C2=C1C(C1OC3=CC(O)=CC(O)=C3CC1O)=CC(O)=C2O UXRMWRBWCAGDQB-UHFFFAOYSA-N 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 239000012264 purified product Substances 0.000 description 5
- IPMYMEWFZKHGAX-ZKSIBHASSA-N theaflavin Chemical compound C1=C2C([C@H]3OC4=CC(O)=CC(O)=C4C[C@H]3O)=CC(O)=C(O)C2=C(O)C(=O)C=C1[C@@H]1[C@H](O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-ZKSIBHASSA-N 0.000 description 5
- 229940026509 theaflavin Drugs 0.000 description 5
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 239000001116 FEMA 4028 Substances 0.000 description 3
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 3
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 3
- 229960004853 betadex Drugs 0.000 description 3
- -1 cyclic oligosaccharide Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 229940074391 gallic acid Drugs 0.000 description 3
- 235000004515 gallic acid Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- AATSUYYYTHJRJO-UHFFFAOYSA-N theaflavin 3-gallate Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(=CC(=O)C(O)=C1C(O)=C2O)C=C1C=C2C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 AATSUYYYTHJRJO-UHFFFAOYSA-N 0.000 description 3
- 235000007900 theaflavin-3-gallate Nutrition 0.000 description 3
- AATSUYYYTHJRJO-RZYARBFNSA-N theaflavin-3-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C1=C(O)C(O)=C2C(=O)C(O)=CC(=CC2=C1)[C@H]1OC2=CC(O)=CC(O)=C2C[C@H]1O)C(=O)C1=CC(O)=C(O)C(O)=C1 AATSUYYYTHJRJO-RZYARBFNSA-N 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 2
- BVMDSEFJGKQBKJ-UHFFFAOYSA-N Theaflavin 3'-gallate Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O BVMDSEFJGKQBKJ-UHFFFAOYSA-N 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 2
- 235000019225 fermented tea Nutrition 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- LVJJFMLUMNSUFN-UHFFFAOYSA-N gallocatechin gallate Natural products C1=C(O)C=C2OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C1OC(=O)C1=CC(O)=C(O)C(O)=C1 LVJJFMLUMNSUFN-UHFFFAOYSA-N 0.000 description 2
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 2
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000020333 oolong tea Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- POECFFCNUXZPJT-UHFFFAOYSA-M sodium;carbonic acid;hydrogen carbonate Chemical compound [Na+].OC(O)=O.OC([O-])=O POECFFCNUXZPJT-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 229940092665 tea leaf extract Drugs 0.000 description 2
- IKLDTEFDTLKDRK-UHFFFAOYSA-N theaflavin 3'-gallate Natural products OC1Cc2c(O)cc(O)cc2OC1c3cc4C=C(C=C(O)C(=O)c4c(O)c3O)C5Oc6cc(O)cc(O)c6CC5OC(=O)c7cc(O)c(O)c(O)c7 IKLDTEFDTLKDRK-UHFFFAOYSA-N 0.000 description 2
- 235000002365 theaflavin-3'-gallate Nutrition 0.000 description 2
- 229940026510 theanine Drugs 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- XMOCLSLCDHWDHP-SWLSCSKDSA-N (+)-Epigallocatechin Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-SWLSCSKDSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- LSHVYAFMTMFKBA-PZJWPPBQSA-N (+)-catechin-3-O-gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-PZJWPPBQSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- WMBWREPUVVBILR-GHTZIAJQSA-N (+)-gallocatechin gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-GHTZIAJQSA-N 0.000 description 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- ZEASWHWETFMWCV-ISBUVJFSSA-N Theaflavin 3,3'-digallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C2=CC(=CC(=O)C(O)=C2C(O)=C(O)C=1)[C@@H]1[C@@H](CC2=C(O)C=C(O)C=C2O1)OC(=O)C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 ZEASWHWETFMWCV-ISBUVJFSSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000010376 calcium ascorbate Nutrition 0.000 description 1
- 229940047036 calcium ascorbate Drugs 0.000 description 1
- 239000011692 calcium ascorbate Substances 0.000 description 1
- BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- JYYOBHFYCIDXHH-UHFFFAOYSA-N carbonic acid;hydrate Chemical compound O.OC(O)=O JYYOBHFYCIDXHH-UHFFFAOYSA-N 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 229940030275 epigallocatechin gallate Drugs 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Landscapes
- Tea And Coffee (AREA)
- Non-Alcoholic Beverages (AREA)
Description
本発明は、テアフラビン類を高濃度に含む飲料に関する。また本発明は、テアフラビン類を高濃度に含む飲料の呈味改善方法や沈殿発生抑制方法に関する。
に関する。
The present invention relates to a beverage containing theaflavins at a high concentration. The present invention also relates to a method for improving the taste of beverages containing theaflavins at high concentrations and a method for suppressing precipitation.
About.
容器詰紅茶飲料は多くの人に愛飲されている嗜好性が高い飲料の一つであり、いつでも手軽に紅茶飲料を楽しむことができるため、その利便性により消費者ニーズが拡大してきた。このニーズに応えるため、紅茶飲料を工業的に生産した容器詰紅茶飲料が数多く上市されている。 Containerized tea beverages are one of the highly favorite beverages that are loved by many people, and since tea beverages can be easily enjoyed at any time, consumer needs have expanded due to their convenience. In order to meet this need, a large number of containerized black tea beverages produced industrially for black tea beverages are on the market.
近年、消費者の健康志向が進むことにより、各種機能性を備えた飲食物が上市されるようになってきた。とりわけ植物由来の機能成分を高濃度に飲食物に配合することにより、該飲食物を摂取すれば、当該成分の好ましい生理活性が享受できるように設計された飲食物が増加してきた。 In recent years, as consumers become more health-conscious, foods and drinks with various functionalities have been put on the market. In particular, foods and drinks designed to enjoy the favorable physiological activity of the component have been increased by ingesting the food and drink by blending the plant-derived functional ingredient in the food and drink at a high concentration.
これまで、特定の機能性を有する植物由来成分としては様々な種類のものがある。例えば茶(Camellia sinensis)由来の成分としては、例えばカテキン類、テアニン、カフェイン等がよく知られている。カテキン類には、抗酸化作用、血糖値上昇抑制作用、体脂肪蓄積抑制作用、抗菌作用、抗アレルギー作用などがあることがあり(非特許文献1)、テアニンには、脳神経機能調節作用などがあることが(非特許文献2)、カフェインには自律神経活性化作用や抗炎症・抗アレルギー作用(非特許文献2)があることがそれぞれ知られている。実際、カテキン類の抗肥満作用やコレステロール低下作用を有する容器詰飲料がすでに市場に出ている。 Until now, there are various kinds of plant-derived components having specific functionality. For example, catechins, theanine, caffeine and the like are well known as components derived from tea (Camellia sinensis). Catechins may have anti-oxidant action, blood sugar level increase-inhibiting action, body fat accumulation-inhibiting action, antibacterial action, anti-allergic action, etc. (Non-patent Document 1), and theanine has cranial nerve function regulating action, etc. It is known (Non-Patent Document 2) that caffeine has an autonomic nerve activation action and an anti-inflammatory / anti-allergic action (Non-Patent Document 2). In fact, packaged beverages having the anti-obesity action and cholesterol-lowering action of catechins are already on the market.
発酵茶において特に多く含まれるテアフラビン類には、例えばコレステロール低下作用(特許文献1)や、リパーゼ阻害作用(特許文献2)や、脂質吸収阻害作用(特許文献3)があることがすでに知られている。テアフラビン類の機能性を強化した容器詰飲料はまだ市場に出ていないが、テアフラビン類を高濃度に含有する容器詰飲料については記載がある(特許文献4)。 It is already known that the theaflavins that are particularly abundant in fermented tea have, for example, cholesterol lowering action (Patent Document 1), lipase inhibitory action (Patent Document 2), and lipid absorption inhibitory action (Patent Document 3). Yes. Although packaged beverages with enhanced functionality of theaflavins have not yet been put on the market, there is a description of packaged beverages containing theaflavins in high concentrations (Patent Document 4).
しかし、テアフラビン類を高濃度に含有する飲料は苦渋味が強いため、テアフラビン類の好ましい生理活性を享受するにしても継続的摂取が難しいという問題があった。また、テアフラビン類を高濃度に含有する飲料は、長期的に保存をするとオリや沈殿が発生しやすいため、特に透明容器詰飲料として商品化した場合には問題である。容器詰飲料中にオリや沈殿が発生していれば消費者の購買意欲を減退させることになり、結果として商品価値を損ねてしまうことになる。 However, since beverages containing theaflavins in high concentrations have a strong bitter taste, there is a problem that continuous ingestion is difficult even if the physiological activity of theaflavins is enjoyed. Also, beverages containing theaflavins in high concentrations are prone to occurrence of sediment and precipitation when stored for a long period of time, which is a problem particularly when commercialized as a transparent container-packed beverage. If orientation or precipitation occurs in the packaged beverage, the consumer's willingness to purchase will be reduced, and as a result, the product value will be impaired.
本発明者らは、このようなテアフラビン類の苦渋味を抑制したり、長期保存時のオリや沈殿の発生を抑制する方法を鋭意検討したところ、テアフラビン高含有飲料中のテアフラビン類と非重合体カテキン類との比率を調整し、さらに当該飲料中にアスコルビン酸若しくはその塩とシクロデキストリンとのいずれか又は両方を添加すると、テアフラビン類の苦渋味を抑制したり、長期保存時のオリや沈殿の発生を抑制したりすることができることを見出し、本発明を完成するに至った。 The present inventors diligently studied a method for suppressing the bitter and astringent taste of such theaflavins, or suppressing the occurrence of orientation and precipitation during long-term storage, and theaflavins and non-polymers in beverages containing a high amount of theaflavins. Adjusting the ratio with catechins and adding either or both of ascorbic acid or its salt and cyclodextrin to the beverage will suppress the bitter taste of theaflavins, It has been found that generation can be suppressed, and the present invention has been completed.
すなわち本発明は、
(1) (A)テアフラビン類と、(B)非重合体カテキン類と、(C)アスコルビン酸及び/又はシクロデキストリンを含有し、以下の要件を満たす容器詰飲料。
(A)0.005〜0.02重量%
(A)/(B)=0.5〜2
(C)=0.01〜0.5重量%
(2) (D)カフェイン含有量が0.005重量%よりも少ないことを特徴とする前記(1)記載の容器詰飲料。
(3) 紅茶抽出物の濃縮物を添加することを特徴とする前記(1)又は(2)記載の容器詰飲料。
(4) シクロデキストリンが高度分岐環状デキストリンであることを特徴とする前記(1)〜(3)のいずれか記載の容器詰飲料。
(5) 容器詰飲料のpHが4.7〜7.0であることを特徴とする前記(1)〜(4)のいずれか記載の容器詰飲料。
(6) 茶系飲料であることを特徴とする前記(1)〜(5)のいずれか記載の容器詰飲料。
(7) (A)テアフラビン類と、(B)非重合体カテキン類と、(C)アスコルビン酸及び/又はシクロデキストリンを以下の条件に調整することを特徴とする容器詰飲料の製造方法。
(A)0.005〜0.02重量%
(A)/(B)=0.5〜2
(C)=0.01〜0.5重量%
(8) 紅茶抽出物の濃縮物を添加することを特徴とする前記(7)記載の容器詰飲料の製造方法。
(9) (A)テアフラビン類と、(B)非重合体カテキン類と、(C)アスコルビン酸及び/又はシクロデキストリンを以下の条件に調整することを特徴とする容器詰飲料の呈味改善方法。
(A)0.005〜0.02重量%
(A)/(B)=0.5〜1.5
(C)=0.01〜0.5重量%
(10) 紅茶抽出物の濃縮物を添加することを特徴とする前記(9)記載の容器詰飲料の呈味改善方法。
(11) (A)テアフラビン類と、(B)非重合体カテキン類と、(C)アスコルビン酸及び/又はシクロデキストリンを以下の条件に調整することを特徴とする容器詰飲料の沈殿発生抑制方法。
(A)0.005〜0.02重量%
(A)/(B)=0.5〜1.5
(C)=0.01〜0.5重量%
(12) (D)カフェイン含有量が0.005重量%よりも少ないことを特徴とする前記(11)記載の容器詰飲料の沈殿発生抑制方法
に関する。
That is, the present invention
(1) A packaged beverage containing (A) theaflavins, (B) non-polymer catechins, and (C) ascorbic acid and / or cyclodextrin and satisfying the following requirements.
(A) 0.005 to 0.02% by weight
(A) / (B) = 0.5-2
(C) = 0.01-0.5% by weight
(2) (D) The packaged beverage according to (1), wherein the caffeine content is less than 0.005% by weight.
(3) The container-packed beverage according to (1) or (2) above, wherein a concentrate of black tea extract is added.
(4) The packaged beverage according to any one of (1) to (3) above, wherein the cyclodextrin is a highly branched cyclic dextrin.
(5) The packaged beverage according to any one of (1) to (4) above, wherein the pH of the packaged beverage is 4.7 to 7.0.
(6) The container-packed beverage according to any one of (1) to (5), which is a tea-based beverage.
(7) A method for producing a packaged beverage characterized by adjusting (A) theaflavins, (B) non-polymer catechins, and (C) ascorbic acid and / or cyclodextrin under the following conditions.
(A) 0.005 to 0.02% by weight
(A) / (B) = 0.5-2
(C) = 0.01-0.5% by weight
(8) The method for producing a packaged beverage according to (7), wherein a concentrate of black tea extract is added.
(9) (A) Theaflavins, (B) Non-polymer catechins, and (C) Ascorbic acid and / or cyclodextrin are adjusted to the following conditions, and a method for improving the taste of a packaged beverage .
(A) 0.005 to 0.02% by weight
(A) / (B) = 0.5-1.5
(C) = 0.01-0.5% by weight
(10) The method for improving the taste of a packaged beverage according to (9), wherein a concentrate of black tea extract is added.
(11) (A) Theaflavins, (B) Non-polymer catechins, and (C) Ascorbic acid and / or cyclodextrin are adjusted to the following conditions, and the method for suppressing precipitation in a packaged beverage is characterized: .
(A) 0.005 to 0.02% by weight
(A) / (B) = 0.5-1.5
(C) = 0.01-0.5% by weight
(12) (D) The caffeine content is less than 0.005% by weight.
本発明は、テアフラビン類を高濃度に含有するにもかかわらず、苦渋味が抑制されており、かつ保存時のオリや沈殿が発生しにくい容器詰飲料やその製造方法を提供することできる。また本発明は、テアフラビン類を高濃度に含有する容器詰飲料の苦渋味を抑制する方法を提供することができる。さらに本発明は、テアフラビン類を高濃度に含有する容器詰飲料の保存時のオリや沈殿の発生を抑制する方法を提供することができる。 The present invention can provide a packaged beverage and a method for producing the same that have a bitter and astringent taste and are less likely to cause orientation and precipitation during storage despite containing a high concentration of theaflavins. Moreover, this invention can provide the method of suppressing the bitter taste of the container-packed drink which contains theaflavins in high concentration. Furthermore, this invention can provide the method of suppressing generation | occurrence | production of the orientation and precipitation at the time of the preservation | save of the container-packed drink which contains theaflavins in high concentration.
本発明において「テアフラビン類」とは、テアフラビン、テアフラビン−3−ガレート、テアフラビン−3’−ガレート、テアフラビン3−3’−ジガレートの総称である。ガレートは、没食子酸(gallic acid)のエステルであり、ガロイル基は没食子酸(gallic acid)から誘導されるアシル基である。
また、「ガレート型テアフラビン類」とは、前記した「テアフラビン類」のうちの没食子酸(gallic acid)のエステルとなっているものであり、具体的には、テアフラビン−3−ガレート、テアフラビン−3’−ガレート、及びテアフラビン−3−3’−ジガレートをいう。
In the present invention, “theaflavins” is a general term for theaflavin, theaflavin-3-gallate, theaflavin-3′-gallate, and theaflavin3-3′-digallate. Galate is an ester of gallic acid and the galloyl group is an acyl group derived from gallic acid.
Further, the “gallate type theaflavins” is an ester of gallic acid among the above-mentioned “theaflavins”, specifically, theaflavin-3-gallate and theaflavin-3. '-Gallate and theaflavin-3-3'-digallate.
本発明の飲料に含まれるテアフラビン類は、テアフラビン類を含む素材(例えば紅茶葉やウーロン茶葉)に天然に含まれるものを抽出して得たものであっても、テアフラビン類の抽出物やその濃縮物、あるいはこれらを含有する組成物を添加してもよい。また、テアフラビン類の抽出物やその濃縮物、あるいはこれらを含有する組成物は、公知方法により得られるものでも、市販のものを用いても良い。本発明においてテアフラビン類の総含有量は、素材から抽出して得られたものと、抽出物やその濃縮物やこれらを含有する組成物由来のものとを合算したものを指す。また、飲料中のテアフラビン類の含有量は、例えば公知のHPLC法に従い測定することができる。 The theaflavins contained in the beverage of the present invention may be those obtained by extracting materials naturally contained in the materials containing theaflavins (for example, black tea leaves and oolong tea leaves), the theaflavins extracts and their concentration Or a composition containing these may be added. Further, the theaflavins extract, the concentrate thereof, or the composition containing them may be obtained by a known method or may be a commercially available one. In the present invention, the total content of theaflavins refers to the total of those obtained by extraction from raw materials and those derived from extracts, concentrates thereof, and compositions containing these. Moreover, content of theaflavins in a drink can be measured, for example according to a well-known HPLC method.
本発明において「非重合体カテキン類」とは、カテキン、ガロカテキン、カテキンガレート、ガロカテキンガレートなどの非エピ体カテキン類と、エピカテキン、エピガロカテキン、エピカテキンガレート、エピガロカテキンガレート等のエピ体カテキン類を合わせての総称である。カテキン類は、カテキン類を含む素材(例えば緑茶葉)に天然に含まれるものを抽出して得たものであっても、カテキン類の抽出物やその濃縮物、あるいはこれらを含有する組成物を添加してもよい。また、カテキン類の抽出物やその濃縮物、あるいはこれらを含有する組成物は、公知方法により得られるものでも、市販のものを用いても良い。本発明においてカテキン類の総含有量は、素材から抽出して得られたものと、抽出物やその濃縮物やこれらを含有する組成物由来のものとを合算したものを指す。また、飲料中のカテキン類の含有量は、例えば公知のHPLC法に従い測定することができる。 In the present invention, “non-polymer catechins” refers to non-epimeric catechins such as catechin, gallocatechin, catechin gallate, and gallocatechin gallate, and epicatechin, epigallocatechin, epicatechin gallate, epigallocatechin gallate and the like. It is a general term for all body catechins. Even if the catechins are obtained by extracting a material naturally contained in a material containing catechins (for example, green tea leaves), an extract of catechins or a concentrate thereof, or a composition containing these is used. It may be added. Moreover, the extract of catechins, the concentrate thereof, or the composition containing these may be obtained by a known method or may be a commercially available product. In the present invention, the total content of catechins refers to the total of those obtained by extraction from raw materials and those derived from extracts, concentrates thereof, and compositions containing these. Moreover, content of the catechins in a drink can be measured, for example according to a well-known HPLC method.
本発明の容器詰飲料における、(A)テアフラビン類と(B)非重合体カテキン類の含有比率(重量比)は、(A)/(B)=0.5〜2、好ましくは0.7〜1.45、さらに好ましくは0.8〜1.7、最も好ましくは0.9〜1.2である。(A)/(B)の値が0.5を下回るとテアフラビン類の摂取量が低くなりすぎることからテアフラビン類の有する好ましい生理活性が得られなくなってしまう。 In the packaged beverage of the present invention, the content ratio (weight ratio) of (A) theaflavins and (B) non-polymer catechins is (A) / (B) = 0.5-2, preferably 0.7. To 1.45, more preferably 0.8 to 1.7, and most preferably 0.9 to 1.2. When the value of (A) / (B) is less than 0.5, the intake amount of theaflavins becomes too low, so that preferable physiological activity possessed by theaflavins cannot be obtained.
本発明におけるテアフラビン類含有量は100mL当りで、3〜20mg、好ましくは5〜20mg、さらに好ましくは7〜20mg、最も好ましくは10〜15mgであるのが好ましい。本発明におけるテアフラビン含有量は、容器詰飲料として市販されている状態のものに含まれる量をいう。また、飲料中のテアフラビン類の含有量は、例えば公知のHPLC法に従い測定することができる。 The theaflavins content in the present invention is preferably 3 to 20 mg, preferably 5 to 20 mg, more preferably 7 to 20 mg, and most preferably 10 to 15 mg per 100 mL. The theaflavin content in this invention says the quantity contained in the thing marketed as a container-packed drink. Moreover, content of theaflavins in a drink can be measured, for example according to a well-known HPLC method.
本発明において「アスコルビン酸」とはアスコルビン酸又はその塩(例えばアスコルビン酸ナトリウムやアスコルビン酸カルシウム)をいい、一般的にはビタミンCと総称される。本発明の飲料に含まれるアスコルビン酸量は、アスコルビン酸又はその塩の総量を指す。アスコルビン酸又はその塩は、公知方法により取得することもできるが市販ものを用いることもでき、また両者を併用してもよい。また、飲料中のアスコルビン酸又はその塩の含有量は、例えば公知のHPLC法に従い測定することができる。 In the present invention, “ascorbic acid” refers to ascorbic acid or a salt thereof (for example, sodium ascorbate or calcium ascorbate), and is generally collectively referred to as vitamin C. The amount of ascorbic acid contained in the beverage of the present invention refers to the total amount of ascorbic acid or a salt thereof. Ascorbic acid or a salt thereof can be obtained by a known method, but a commercially available product can also be used, or both may be used in combination. Moreover, content of ascorbic acid or its salt in a drink can be measured according to a well-known HPLC method, for example.
本発明の「高度分岐環状デキストリン」とは、その化学構造の観点から、内分岐環状構造部分と外分岐構造部分とを有する重合度が50から5000の範囲にあるグルカンとか、内分岐環状構造部分と外分岐構造部分とを有する、重合度が50から5000の範囲にあるグルカンであって、内分岐環状構造部分がα−1,4−グルコシド結合とα−1,6−グルコシド結合とで形成される環状構造により形成され、そして外分岐構造部分が当該内分岐環状構造部分に結合した非環状構造(短いアミロース構造)により形成されているグルカンなどと称されているデキストリン類である。 The “highly branched cyclic dextrin” of the present invention is a glucan having an inner branched cyclic structure portion and an outer branched structure portion in the range of 50 to 5000, or an inner branched cyclic structure portion from the viewpoint of its chemical structure. A glucan having a degree of polymerization in the range of 50 to 5000, and an inner branched cyclic structure portion formed by α-1,4-glucoside bonds and α-1,6-glucoside bonds And dextrins called glucans formed by a non-cyclic structure (short amylose structure) formed by a cyclic structure and having an outer branched structure portion bonded to the inner branched cyclic structure portion.
より詳細には、内分岐環状構造部分と外分岐構造部分とを有する重合度50以上のグルカンであり、このうち、内分岐環状構造部分と外分岐構造部分とを有する重合度が50から5000の範囲にあるグルカンが好ましい。ここで内分岐環状構造部分とはα−1,4−グルコシド結合とα−1,6−グルコシド結合とで形成される環状構造部分であり、そして外分岐構造部とは該内分岐環状構造部分に結合した非環状構造部である。当該高度分岐環状デキストリンにおける内分岐環状構造部分の重合度は10から100の範囲が好ましい。また、外分岐構造部分の重合度は40以上が好ましく、当該外分岐構造部分の各単位鎖の重合度は平均で10から20が好ましい。このような高度分岐環状デキストリンは、日本食品化工(株)から「クラスターデキストリン(登録商標)」という商品名で販売されているものを使用することができる。本明細書では、これらのものを単に「高度分岐環状デキストリン」という。 More specifically, it is a glucan having an inner branch cyclic structure portion and an outer branch structure portion having a degree of polymerization of 50 or more, and among these, the degree of polymerization having an inner branch cyclic structure portion and an outer branch structure portion is 50 to 5000 Glucans in the range are preferred. Here, the inner branched cyclic structure portion is a cyclic structure portion formed by an α-1,4-glucoside bond and an α-1,6-glucoside bond, and the outer branched structure portion is the inner branched cyclic structure portion. It is the non-cyclic structure part couple | bonded with. The degree of polymerization of the inner branched cyclic structure portion in the highly branched cyclic dextrin is preferably in the range of 10 to 100. Further, the degree of polymerization of the outer branch structure portion is preferably 40 or more, and the degree of polymerization of each unit chain of the outer branch structure portion is preferably 10 to 20 on average. As such a highly branched cyclic dextrin, those sold under the trade name “Cluster Dextrin (registered trademark)” by Nippon Shokuhin Kako Co., Ltd. can be used. In the present specification, these are simply referred to as “highly branched cyclic dextrin”.
また、本発明の飲料におけるカフェインの含有量としては、特に制限はないが、飲料全体の0.03質量%以下、好ましくは0.005質量%以下、特に0.0005質量%以下が好ましい。 Moreover, there is no restriction | limiting in particular as content of caffeine in the drink of this invention, However, 0.03 mass% or less of the whole drink, Preferably it is 0.005 mass% or less, Especially 0.0005 mass% or less is preferable.
本発明の「飲料」としては、テアフラビン類を高含有している飲料であれば特に限定されないが、具体的な例としては、例えば茶類飲料(緑茶飲料、紅茶飲料、ウーロン茶飲料)、穀物抽出飲料(麦茶、豆茶、トウモロコシ茶など)、コーヒー飲料、野菜飲料、果実飲料、乳酸菌飲料、炭酸飲料、天然水、スポーツ用飲料、各種機能性飲料等が挙げられるが、茶系飲料、とりわけ紅茶飲料が好ましい。 The “beverage” of the present invention is not particularly limited as long as it is a beverage containing a high amount of theaflavins. Specific examples include tea beverages (green tea beverages, tea beverages, oolong tea beverages), grain extraction, and the like. Beverages (barley tea, bean tea, corn tea, etc.), coffee drinks, vegetable drinks, fruit drinks, lactic acid bacteria drinks, carbonated drinks, natural waters, sports drinks, various functional drinks, etc., tea drinks, especially tea Beverages are preferred.
また本発明の「茶系飲料」としては、茶葉、好ましくは半発酵茶葉、より好ましくは発酵茶葉からの抽出物、又はその濃縮物が添加された飲料に適した呈味を有するものが挙げられる。好ましくはテアフラビン類の濃度が飲料全体の0.0015質量%(15ppm)以上、好ましくは0.005質量%(50ppm)以上、より好ましくは0.01質量%(100ppm)以上、さらに好ましくは0.015質量%(150ppm)以上の茶葉からの抽出物、又はその濃縮物が添加された飲料が挙げられる。本発明の好ましい飲料としては、紅茶系飲料が挙げられる。本発明の飲料は、テアフラビン類の濃度を高めるために必要に応じて茶葉の抽出物の濃縮物や、高濃度でテアフラビン類を含有するテアフラビン類の濃縮物を、水や茶抽出物などの飲料に添加して飲料とすることもできる。 In addition, the “tea-based beverage” of the present invention includes a tea leaf, preferably a semi-fermented tea leaf, more preferably an extract from a fermented tea leaf, or a beverage having a taste suitable for a beverage to which a concentrate thereof is added. . The concentration of theaflavins is preferably 0.0015% by mass (15 ppm) or more, preferably 0.005% by mass (50 ppm) or more, more preferably 0.01% by mass (100 ppm) or more, and still more preferably 0.005% by mass or more. Examples include beverages to which 015% by mass (150 ppm) or more of tea leaf extract or its concentrate has been added. A preferred beverage of the present invention is a black tea beverage. In order to increase the concentration of theaflavins, the beverage of the present invention can be obtained by concentrating a tea leaf extract concentrate or a theaflavin concentrate containing theaflavins at a high concentration, such as water or tea extract. It can also be added to a beverage.
本発明の飲料における非重合体カテキン類の含有量としては、テアフラビン類と非重合体カテキン類との比[(A)/(B)]が、0.5〜2、好ましくは0.6〜1.5、より好ましくは0.8〜1であることが挙げられる。また、テアフラビン類と非重合体カテキン類との和[(A)+(B)]としては、0.005質量%〜0.03質量%、好ましくは0.007質量%〜0.029質量%であることが挙げられる。 As content of non-polymer catechins in the beverage of the present invention, the ratio [(A) / (B)] of theaflavins and non-polymer catechins is 0.5-2, preferably 0.6-. It is 1.5, More preferably, it is 0.8-1. Moreover, as the sum [(A) + (B)] of theaflavins and non-polymer catechins, 0.005% by mass to 0.03% by mass, preferably 0.007% by mass to 0.029% by mass. It is mentioned that.
また、本発明の飲料におけるカフェインの含有量としては、特に制限はないが、飲料全体の0.01質量%未満、好ましくは0.005質量%以下、特に0.0005質量%以下が好ましい。 Moreover, there is no restriction | limiting in particular as content of caffeine in the drink of this invention, However, Less than 0.01 mass% of the whole drink, Preferably it is 0.005 mass% or less, Especially 0.0005 mass% or less is preferable.
本発明の容器詰飲料におけるテアフラビン類、非重合体カテキン類、及びカフェインなどの含有量の測定方法としては、公知の方法で、例えば、公知のHPLC法により公知の方法で測定することができる。 The content of the theaflavins, non-polymer catechins, and caffeine in the packaged beverage of the present invention can be measured by a known method, for example, by a known HPLC method. .
本発明におけるシクロデキストリンとしては、グルコースが環状につながったものであって、好ましいシクロデキストリンとしては、α−、β−、γ−シクロデキストリン及び分岐α−、β−、γ−シクロデキストリン、前記した高度分岐環状デキストリン等が挙げられる。本発明におけるシクロデキストリンの使用量としては、飲料全体に対して0.01〜0.5質量%が好ましい。本発明における環状オリゴ糖を後述するアスコルビン酸(ビタミンC)又はその塩と併用して使用する場合には、飲料全体に対して0.001〜0.5質量%であってもよい。 As the cyclodextrin in the present invention, glucose is cyclically linked, and preferable cyclodextrins include α-, β-, γ-cyclodextrin and branched α-, β-, γ-cyclodextrin, as described above. Examples include highly branched cyclic dextrins. As the usage-amount of the cyclodextrin in this invention, 0.01-0.5 mass% is preferable with respect to the whole drink. When using the cyclic oligosaccharide in this invention in combination with ascorbic acid (vitamin C) mentioned later or its salt, 0.001-0.5 mass% may be sufficient with respect to the whole drink.
本発明の容器詰飲料に添加されるアスコルビン酸(ビタミンC)又はその塩は、アスコルビン酸(ビタミンC)又はその塩を本発明の飲料に直接添加配合してもよいが、遊離のアスコルビン酸(ビタミンC)として使用し、これを重曹などで中和して使用することもできる。アスコルビン酸(ビタミンC)又はその塩の配合量としては、遊離のアスコルビン酸(ビタミンC)に換算して飲料全体に対して0.01〜0.5質量%、好ましくは0.01〜0.05質量%である。 Ascorbic acid (vitamin C) or a salt thereof added to the container-packed beverage of the present invention may be directly added and blended with ascorbic acid (vitamin C) or a salt thereof to the beverage of the present invention. It can also be used as vitamin C), neutralized with baking soda or the like. As a compounding quantity of ascorbic acid (vitamin C) or its salt, it is 0.01-0.5 mass% in conversion to free ascorbic acid (vitamin C), Preferably it is 0.01-0. 05% by mass.
また、アスコルビン酸(ビタミンC)又はその塩を併用する場合には、容器詰飲料のpHが25℃で約3〜7、好ましくは4〜7、より好ましくは4.4〜6.5程度となるように調整するのが好ましい。 Moreover, when using ascorbic acid (vitamin C) or its salt together, the pH of a packaged drink is about 3-7 at 25 degreeC, Preferably it is 4-7, More preferably, it is about 4.4-6.5. It is preferable to adjust so that it becomes.
本発明の飲料は、必要に応じてさらに苦味抑制剤を配合することもできる。苦味抑制剤としては、水溶性高分子が好ましい。水溶性高分子としては、ペクチン、デキストリン等が挙げられる。本発明の茶飲料には、さらに、酸化防止剤、香料、各種エステル類、有機酸類、有機酸塩類、無機酸類、無機酸塩類、無機塩類、色素類、乳化剤、保存料、調味料、pH調整剤、品質安定剤などの添加剤を単独、あるいは併用して配合することもできる。 The beverage of the present invention can further contain a bitterness inhibitor as necessary. As the bitterness inhibitor, a water-soluble polymer is preferable. Examples of the water-soluble polymer include pectin and dextrin. The tea beverage of the present invention further includes antioxidants, fragrances, various esters, organic acids, organic acid salts, inorganic acids, inorganic acid salts, inorganic salts, pigments, emulsifiers, preservatives, seasonings, pH adjustments. Additives such as agents and quality stabilizers can be used alone or in combination.
本発明の容器詰飲料は、飲料を容器に詰めて製造される。使用される容器としては、PETボトル、金属缶、金属箔やプラスチックフィルムと複合された紙容器、瓶などの通常の容器を使用することができる。本発明の容器詰飲料としては、通常は希釈せずに飲用できるものであるが、これに限定されるものではない。 The container-packed beverage of the present invention is produced by filling a beverage in a container. Usable containers include ordinary containers such as PET bottles, metal cans, paper containers combined with metal foils and plastic films, and bottles. The container-packed beverage of the present invention is usually drinkable without dilution, but is not limited thereto.
また、本発明の容器詰飲料は、例えば、金属缶のように容器に充填後、加熱殺菌できる場合にあっては食品衛生法に定められた殺菌条件で製造される。PETボトル、紙容器のようにレトルト殺菌できないものについては、あらかじめ上記と同等の殺菌条件、例えばプレート式熱交換器などで高温短時間殺菌後、一定の温度まで冷却して容器に充填する等の方法により製造することができる。また、無菌下で、充填された容器に別の成分を配合して充填してもよい。 Moreover, the container-packed drink of this invention is manufactured on the sterilization conditions prescribed | regulated to the food hygiene law, for example, when it can heat-sterilize after filling a container like a metal can. For PET bottles and paper containers that cannot be sterilized by retort, sterilize under the same conditions as above, for example, after sterilizing at high temperature and short time with a plate heat exchanger, etc. It can be manufactured by a method. Moreover, you may mix | blend another component with the filled container under aseptic conditions.
以下、実施例により本発明をより具体的に説明するが、本発明はこれらの実施例により何ら限定されるものではない。 EXAMPLES Hereinafter, although an Example demonstrates this invention more concretely, this invention is not limited at all by these Examples.
(実施例1:サンプル調製)
表1に記載の紅茶精製物を使用して容器詰飲料を製造した。なお、表1中のTFはテアフラビンを表し、TF3gはテアフラビン−3−ガレートを表し、TF3’gはテアフラビン−3’−ガレートを表し、TFdgはテアフラビン−3−3’−ジガレートをそれぞれ表す。
(Example 1: Sample preparation)
Containerized beverages were produced using the purified tea products listed in Table 1. In Table 1, TF represents theaflavin, TF3g represents theaflavin-3-gallate, TF3′g represents theaflavin-3′-gallate, and TFdg represents theaflavin-3-3′-digallate.
表1の紅茶精製物を水に溶解してサンプルとなる容器詰飲料を製造した。飲料中の紅茶精製物の濃度が0.0875重量%となるようにまずは調整し、得られた紅茶精製物を用いて以下記載のサンプル1〜7を製造した。なお、いずれのサンプルにおいても、テアフラビン類と非重合体カテキン類との比率(テアフラビン類/非重合体カテキン類)を0.697〜1.078の範囲に調整し、テアフラビン類の含有量も0.0106〜0.0142重量%の範囲に調整することにより、サンプル間のバラツキを抑えた。 The bottled beverage used as a sample was manufactured by dissolving the tea purified product of Table 1 in water. First, samples 1 to 7 described below were produced using the obtained black tea refined product by adjusting the concentration of the black tea refined product in the beverage to 0.0875% by weight. In any sample, the ratio of theaflavins and non-polymer catechins (theaflavins / non-polymer catechins) was adjusted to a range of 0.697 to 1.078, and the content of theaflavins was also 0. By adjusting to the range of 0.0106 to 0.0142% by weight, variation between samples was suppressed.
(サンプル1)
表1の紅茶精製物を水に溶解したサンプル液(紅茶精製物濃度:0.0875重量%)をそのまま金属缶に充填し、UHT殺菌した。UHT殺菌前のpHは4.92であった。
(Sample 1)
A sample solution (tea refined product concentration: 0.0875% by weight) obtained by dissolving the tea refined product in Table 1 in water was filled in a metal can as it was and sterilized by UHT. The pH before UHT sterilization was 4.92.
(サンプル2)
表1の紅茶精製物を水に溶解したサンプル液(紅茶精製物濃度:0.0875重量%)に炭酸水素ナトリウム(重曹)を適量添加してpH調整してから金属缶に充填し、UHT殺菌した。UHT殺菌前のpHは6.4であった。
(Sample 2)
Add a proper amount of sodium hydrogen carbonate (sodium bicarbonate) to a sample solution (tea refined product concentration: 0.0875 wt%) dissolved in water in Table 1 and adjust the pH, then fill into a metal can and sterilize UHT did. The pH before UHT sterilization was 6.4.
(サンプル3)
紅茶精製物を水に溶解したサンプル液(紅茶精製物濃度:0.0875重量%)に高度分岐環状デキストリン(クラスターデキストリン、CCD)を0.3重量%添加してから金属缶に充填し、UHT殺菌した。UHT殺菌前のpHは4.99であった。
(Sample 3)
After adding 0.3% by weight of highly branched cyclic dextrin (cluster dextrin, CCD) to a sample solution (tea purified product concentration: 0.0875% by weight) in which black tea product is dissolved in water, it is filled into a metal can, and UHT Sterilized. The pH before UHT sterilization was 4.99.
(サンプル4)
紅茶精製物を水に溶解したサンプル液(紅茶精製物濃度:0.0875重量%)にアスコルビン酸を0.03重量%添加し、さらに炭酸水素ナトリウム(重曹)を適量添加してpH調整してから金属缶に充填し、UHT殺菌した。UHT殺菌前のpHは6.53であった。
(Sample 4)
Add 0.03% by weight of ascorbic acid to a sample liquid (tea purified product concentration: 0.0875% by weight) dissolved in water and adjust the pH by adding an appropriate amount of sodium hydrogen carbonate (bicarbonate). Were filled into metal cans and UHT sterilized. The pH before UHT sterilization was 6.53.
(サンプル5)
紅茶精製物を水に溶解したサンプル液(紅茶精製物濃度:0.0875重量%)にアスコルビン酸を0.03重量%添加し、さらに高度分岐環状デキストリン(クラスターデキストリン、CCD)を0.3重量%添加し、炭酸水素ナトリウム(重曹)を適量添加してpH調整してから金属缶に充填し、UHT殺菌した。UHT殺菌前のpHは6.46であった。
(Sample 5)
0.03% by weight of ascorbic acid is added to a sample liquid (tea purified product concentration: 0.0875% by weight) dissolved in water, and 0.3% by weight of highly branched cyclic dextrin (cluster dextrin, CCD). %, Sodium bicarbonate (sodium bicarbonate) was added in an appropriate amount to adjust pH, and then filled into a metal can and sterilized with UHT. The pH before UHT sterilization was 6.46.
(サンプル6)
紅茶精製物を水に溶解したサンプル液(紅茶精製物濃度:0.0875重量%)にアスコルビン酸を0.03重量%添加し、さらに高度分岐環状デキストリン(クラスターデキストリン、CCD)を0.003重量%添加し、炭酸水素ナトリウム(重曹)を適量添加してpH調整してから金属缶に充填し、UHT殺菌した。UHT殺菌前のpHは6.58であった。
(Sample 6)
0.03% by weight of ascorbic acid is added to a sample solution (black tea concentration: 0.0875% by weight) obtained by dissolving a purified black tea product in water, and 0.003% by weight of highly branched cyclic dextrin (cluster dextrin, CCD). %, Sodium bicarbonate (sodium bicarbonate) was added in an appropriate amount to adjust pH, and then filled into a metal can and sterilized with UHT. The pH before UHT sterilization was 6.58.
(サンプル7)
紅茶精製物を水に溶解したサンプル液(紅茶精製物濃度:0.0875重量%)にアスコルビン酸を0.3重量%添加し、さらにβ―サイクロデキストリンを0.003重量%添加し、炭酸水素ナトリウム(重曹)を適量添加してpH調整してから金属缶に充填し、UHT殺菌した。UHT殺菌前のpHは6.55であった。
これらの各サンプルの成分を次の表2に示す。
(Sample 7)
0.3% by weight of ascorbic acid and 0.003% by weight of β-cyclodextrin are added to a sample liquid (tea purified product concentration: 0.0875% by weight) dissolved in water, and hydrogen carbonate is added. Sodium (sodium bicarbonate) was added in an appropriate amount to adjust the pH, and then filled into a metal can and sterilized with UHT. The pH before UHT sterilization was 6.55.
The components of each of these samples are shown in Table 2 below.
(実施例2:(1)官能評価)
上記で得られたサンプル1〜7を5℃で暗所保管(35日経過後)に、専門家が飲料の風味とりわけテアフラビン類の苦味や渋味に着目した官能評価を行った。
(実施例2:(2)沈殿抑制効果)
次に、上記で得られたサンプル1〜7を5℃で暗所保管(35日経過後)後における沈殿発生抑制効果を調べた。
これらの試験の結果をまとめて次の表3に示す。
(Example 2: (1) Sensory evaluation)
The samples 1 to 7 obtained above were stored in the dark at 5 ° C. (after 35 days), and an expert performed sensory evaluation focusing on the flavor of beverages, particularly the bitterness and astringency of theaflavins.
(Example 2: (2) precipitation suppression effect)
Next, the effect of suppressing the occurrence of precipitation after the samples 1 to 7 obtained above were stored at 5 ° C. in the dark (after 35 days).
The results of these tests are summarized in Table 3 below.
サンプル1とサンプル2は、テアフラビン類の苦味や渋味が強く飲用に適さないことを示している。また、炭酸水素ナトリウム(重曹)を適量添加してpH調整しても飲用適性はほとんど改善せず(サンプル2)、炭酸水素ナトリウム(重曹)が与える影響は僅かであると判断した。 Samples 1 and 2 indicate that theaflavins have a strong bitterness and astringency and are not suitable for drinking. Further, even if an appropriate amount of sodium hydrogen carbonate (bicarbonate) was added to adjust the pH, the potability was hardly improved (sample 2), and it was judged that the effect of sodium bicarbonate (bicarbonate) was slight.
一方、アスコルビン酸と炭酸水素ナトリウム(重曹)とを添加したサンプル4では、テアフラビン類の苦渋味が弱くなり、サンプル1とサンプル2と比較して飲用適性が極めて向上した。上述のとおり、炭酸水素ナトリウム(重曹)の飲用適性への影響は僅かであるため、ビタミンCの添加が飲用適性を向上させることがわかった。 On the other hand, in sample 4 to which ascorbic acid and sodium bicarbonate (sodium bicarbonate) were added, the bitter and astringent taste of theaflavins was weakened, and the drinkability was greatly improved as compared with samples 1 and 2. As described above, it has been found that the addition of vitamin C improves the drinkability because sodium bicarbonate (sodium bicarbonate) has little effect on the drinkability.
次に、高度分岐環状デキストリンやβ―サイクロデキストリンを添加してサンプル飲料の飲用特性が向上するかを調べた。最も飲用適性に優れたサンプル(サンプル5)では、アスコルビン酸0.03重量%と高度分岐環状デキストリンを0.3重量%とを含有している。次に飲用適性の評価が高かったサンプル(サンプル3)では、高度分岐環状デキストリンを0.3重量%を添加したものであったが、アスコルビン酸0.03重量%を添加したサンプル(サンプル4)も飲用適性についてサンプル3と殆ど差異はなかった。このことから、テアフラビン類を高濃度に含有する飲料において、テアフラビン類が有する苦味や渋味を抑制するためには、アスコルビン酸と高度分岐環状デキストリンとのいずれか又は両方が有効であることがわかった。 Next, it was investigated whether the drinking characteristics of the sample beverage could be improved by adding highly branched cyclic dextrin or β-cyclodextrin. The sample (Sample 5) most excellent in drinkability contains 0.03% by weight of ascorbic acid and 0.3% by weight of highly branched cyclic dextrin. Next, in the sample (sample 3) having the highest evaluation of drinking ability, 0.3% by weight of highly branched cyclic dextrin was added, but the sample to which 0.03% by weight of ascorbic acid was added (sample 4). However, there was almost no difference in the drinkability from Sample 3. This indicates that in beverages containing theaflavins at high concentrations, either or both of ascorbic acid and highly branched cyclic dextrins are effective to suppress the bitterness and astringency of theaflavins. It was.
飲用適性が次に優れていたものはβ−サイクロデキストリンを0.03重量%添加したサンプルであった(サンプル7)。サンプル7では、テアフラビン類が有する苦味や渋味がある程度抑制されたが、サンプル3〜5と比較して糖質由来の不自然な甘みが感じられたため、飲用適性はやや低かった。 The sample having the next best drinking ability was a sample to which β-cyclodextrin was added in an amount of 0.03% by weight (Sample 7). In Sample 7, the bitterness and astringency of the theaflavins were suppressed to some extent, but the sugar-derived unnatural sweetness was felt compared to Samples 3-5, so the drinking ability was slightly low.
なおサンプル6は、アスコルビン酸(0.03重量%)と高度分岐環状デキストリン(0.003重量%)とを含有する飲料は、サンプル4と比較して評価が低かった。アスコルビン酸と高度分岐環状デキストリンとはいずれもテアフラビン高濃度飲料の飲用適性を向上させるようにも思えるものの、両者を併用したサンプル6はサンプル4と比較して評価が低かった。
以上の飲用適性の結果をまとめると、好ましい順位は以下の通りとなる。
サンプル5>サンプル3>サンプル4>サンプル7>サンプル6
In addition, as for the sample 6, the drink containing ascorbic acid (0.03% by weight) and highly branched cyclic dextrin (0.003% by weight) was lower in evaluation than the sample 4. Although both ascorbic acid and highly branched cyclic dextrin seem to improve the drinking suitability of the theaflavin high-concentration beverage, the sample 6 used in combination with both has a lower evaluation than the sample 4.
Summarizing the above results of drinkability, the preferred order is as follows.
Sample 5> Sample 3> Sample 4> Sample 7> Sample 6
また、沈殿抑制効果の結果では、サンプル1では明らかに沈殿発生が発生したのに対して、サンプル4から7では沈殿は殆ど発生しなかった。一方、サンプル2から3では、若干の沈殿発生が観察されたが極めて微量であって、サンプル1と比較して沈殿物は極めて少なく製品上問題ないと判断された。 In addition, as a result of the precipitation suppression effect, precipitation occurred clearly in sample 1, whereas precipitation hardly occurred in samples 4 to 7. On the other hand, in Samples 2 to 3, a slight amount of precipitation was observed, but the amount was very small, and compared with Sample 1, the amount of precipitate was very small, and it was judged that there was no problem in terms of product.
Claims (4)
(A)テアフラビン類と、(B)非重合体カテキン類と、(C)アスコルビン酸を、又はさらに(D)シクロデキストリンを、以下の条件に調整することを特徴とする容器詰飲料の長期保存時の沈殿発生抑制方法。
(A)0.005〜0.02重量%
(A)/(B)=0.5〜1.5
(C)=0.01〜0.5重量%
(D)=0.001〜0.5重量% In a packaged beverage containing 0.005% by weight or more of theaflavins and having a caffeine content of less than 0.005% by weight,
Long-term storage of packaged beverages characterized by adjusting (A) theaflavins, (B) non-polymer catechins, (C) ascorbic acid , or (D) cyclodextrin to the following conditions: To prevent precipitation at the time .
(A) 0.005 to 0.02% by weight
(A) / (B) = 0.5-1.5
(C) = 0.01-0.5% by weight
(D) = 0.001 to 0.5% by weight
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008268219A JP4695684B2 (en) | 2008-10-17 | 2008-10-17 | Beverages containing high-concentration theaflavins |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008268219A JP4695684B2 (en) | 2008-10-17 | 2008-10-17 | Beverages containing high-concentration theaflavins |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010094084A JP2010094084A (en) | 2010-04-30 |
JP4695684B2 true JP4695684B2 (en) | 2011-06-08 |
Family
ID=42256222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008268219A Active JP4695684B2 (en) | 2008-10-17 | 2008-10-17 | Beverages containing high-concentration theaflavins |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4695684B2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014117224A (en) * | 2012-12-17 | 2014-06-30 | Asahi Soft Drinks Co Ltd | Drink having black tea-like flavor |
JP6621236B2 (en) * | 2013-12-26 | 2019-12-18 | 花王株式会社 | Method for producing catechin-containing beverage |
JP2015146758A (en) * | 2014-02-06 | 2015-08-20 | 花王株式会社 | manufacturing method of catechin-containing beverage |
JP2016029932A (en) * | 2014-07-30 | 2016-03-07 | 花王株式会社 | Method for preparing catechin-containing beverage |
JP6758466B2 (en) * | 2019-09-04 | 2020-09-23 | サントリーホールディングス株式会社 | Furaneol-derived off-flavour-reduced beverage |
CN115361942A (en) * | 2020-04-10 | 2022-11-18 | 马提亚斯·W·拉斯 | Pharmaceutical composition and application thereof in inhibiting expression of membrane ACE2 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003171297A (en) * | 2001-12-07 | 2003-06-17 | Ito En Ltd | Blood bilirubin concentration depressant and medicine for treatment/prevention of jaundice |
JP2004254511A (en) * | 2003-02-24 | 2004-09-16 | Kao Corp | Method for producing packaged beverage |
JP2004305012A (en) * | 2003-04-02 | 2004-11-04 | Ito En Ltd | Method for producing decaffeinated natural plant extract |
JP2005160394A (en) * | 2003-12-03 | 2005-06-23 | Kao Corp | Packed tea beverage |
JP2006174748A (en) * | 2004-12-22 | 2006-07-06 | Kao Corp | Producing process of packaged green tea beverage |
JP2008125428A (en) * | 2006-11-20 | 2008-06-05 | Mitsui Norin Co Ltd | Packaged black tea beverage containing high concentration black tea polyphenol |
JP2008148588A (en) * | 2006-12-14 | 2008-07-03 | Taiyo Kagaku Co Ltd | Polyphenol composition |
-
2008
- 2008-10-17 JP JP2008268219A patent/JP4695684B2/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003171297A (en) * | 2001-12-07 | 2003-06-17 | Ito En Ltd | Blood bilirubin concentration depressant and medicine for treatment/prevention of jaundice |
JP2004254511A (en) * | 2003-02-24 | 2004-09-16 | Kao Corp | Method for producing packaged beverage |
JP2004305012A (en) * | 2003-04-02 | 2004-11-04 | Ito En Ltd | Method for producing decaffeinated natural plant extract |
JP2005160394A (en) * | 2003-12-03 | 2005-06-23 | Kao Corp | Packed tea beverage |
JP2006174748A (en) * | 2004-12-22 | 2006-07-06 | Kao Corp | Producing process of packaged green tea beverage |
JP2008125428A (en) * | 2006-11-20 | 2008-06-05 | Mitsui Norin Co Ltd | Packaged black tea beverage containing high concentration black tea polyphenol |
JP2008148588A (en) * | 2006-12-14 | 2008-07-03 | Taiyo Kagaku Co Ltd | Polyphenol composition |
Also Published As
Publication number | Publication date |
---|---|
JP2010094084A (en) | 2010-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3597856B2 (en) | Packaged tea beverage | |
EP1297749B1 (en) | Beverages containing tea extract | |
TWI406633B (en) | Packaged green tea beverage | |
JP4695684B2 (en) | Beverages containing high-concentration theaflavins | |
JP5330756B2 (en) | Container drink | |
JP4768666B2 (en) | Container drink | |
JP5931519B2 (en) | Tea leaf pectin-containing beverage | |
JP4823877B2 (en) | Method for producing tea beverage | |
JP4940047B2 (en) | Container drink | |
JP5517421B2 (en) | Container drink | |
JP4884003B2 (en) | Container oolong tea drink | |
JP4774002B2 (en) | Container drink | |
JP4745928B2 (en) | High polyphenol content beverage with reduced bitterness and astringency | |
JP3597839B2 (en) | Packaged tea beverage | |
JP4782753B2 (en) | Container drink | |
CN102933099A (en) | Product comprising catechins | |
JP4705599B2 (en) | Container drink | |
JP2010532980A (en) | Stable and consumable composition | |
JP4768667B2 (en) | Container drink | |
JP2007319075A (en) | Packaged beverage | |
JP4722985B2 (en) | Packaged beverages containing theaflavins | |
JP6639372B2 (en) | Tea beverage containing high concentration inulin | |
JP4383335B2 (en) | Manufacturing method for packaged tea beverages | |
JP4383329B2 (en) | Containerized tea beverage | |
JP4838204B2 (en) | Container drink |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20101028 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101109 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110107 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110201 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110225 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140304 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4695684 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |